Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Dyskinesia, Drug-Induced

phenylmethylsulfonyl fluoride has been researched along with Dyskinesia, Drug-Induced in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodriguez, LA1
Moss, DE1
Reyes, E1
Camarena, ML1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Dyskinesia, Drug-Induced

ArticleYear
Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model.
    Pharmacology, biochemistry, and behavior, 1986, Volume: 25, Issue:6

    Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Disease Models, Animal; Dopamine Antagonists;

1986